Skip to main content
Top
Gepubliceerd in: Quality of Life Research 11/2020

06-06-2020 | Review

Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review

Auteurs: Elke Rammant, Lisa Van Wilder, Mieke Van Hemelrijck, Nele S. Pauwels, Karel Decaestecker, Charles Van Praet, Renée Bultijnck, Piet Ost, Thomas Van Vaerenbergh, Sofie Verhaeghe, Ann Van Hecke, Valérie Fonteyne

Gepubliceerd in: Quality of Life Research | Uitgave 11/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

This umbrella review aims to evaluate the quality, summarize and compare the conclusions of systematic reviews investigating the impact of curative treatment options on health-related quality of life (HRQoL) in muscle-invasive bladder cancer (MIBC).

Methods

The Cochrane Library, MEDLINE, Embase and Web of Science were searched independently by two authors from inception until 06 January 2020. Systematic reviews and meta-analyses assessing the impact of any curative treatment option on HRQol in MIBC patients were eligible. Risk of bias was assessed using the AMSTAR 2 tool.

Results

Thirty-two reviews were included. Robot-assisted RC with extracorporeal urinary diversion and open RC have similar HRQoL (n = 10). Evidence for pelvic organ-sparing RC was too limited (n = 2). Patients with a neobladder showed better overall and physical HRQoL outcomes, but worse urinary function in comparison with ileal conduit (n = 17). Bladder-preserving radiochemotherapy showed slightly better urinary and sexual but worse gastro-intestinal HRQoL outcomes in comparison with RC patients (n = 6). Quality of the reviews was low in more than 50% of the available reviews and most of the studies included in the reviews were nonrandomized studies.

Conclusion

This umbrella review gives a comprehensive overview of the available evidence to date.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Witjes, J. A., Lebret, T., Compérat, E. M., Cowan, N. C., De Santis, M., Bruins, H. M., et al. (2017). Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. European Urology, 71(3), 462–475.CrossRef Witjes, J. A., Lebret, T., Compérat, E. M., Cowan, N. C., De Santis, M., Bruins, H. M., et al. (2017). Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. European Urology, 71(3), 462–475.CrossRef
3.
go back to reference Van Rhijn, B. W., Burger, M., Lotan, Y., Solsona, E., Stief, C. G., Sylvester, R. J., et al. (2009). Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy. European Urology, 56(3), 430–442.CrossRef Van Rhijn, B. W., Burger, M., Lotan, Y., Solsona, E., Stief, C. G., Sylvester, R. J., et al. (2009). Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy. European Urology, 56(3), 430–442.CrossRef
4.
go back to reference Mahdavifar, N., Ghoncheh, M., Pakzad, R., Momenimovahed, Z., & Salehiniya, H. (2016). Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pacific Journal of Cancer Prevention, 17(1), 381–386.CrossRef Mahdavifar, N., Ghoncheh, M., Pakzad, R., Momenimovahed, Z., & Salehiniya, H. (2016). Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pacific Journal of Cancer Prevention, 17(1), 381–386.CrossRef
5.
go back to reference Galsky, M. D., Diefenbach, M., Mohamed, N., Baker, C., Pokhriya, S., Rogers, J., et al. (2017). Web-based tool to facilitate shared decision making with regard to neoadjuvant chemotherapy use in muscle-invasive bladder cancer. JCO Clinical Cancer Informatics, 1, 1–12. Galsky, M. D., Diefenbach, M., Mohamed, N., Baker, C., Pokhriya, S., Rogers, J., et al. (2017). Web-based tool to facilitate shared decision making with regard to neoadjuvant chemotherapy use in muscle-invasive bladder cancer. JCO Clinical Cancer Informatics, 1, 1–12.
7.
go back to reference Hu, J. C., Gu, X., Lipsitz, S. R., Barry, M. J., D’Amico, A. V., Weinberg, A. C., et al. (2009). Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA, 302(14), 1557–1564.CrossRef Hu, J. C., Gu, X., Lipsitz, S. R., Barry, M. J., D’Amico, A. V., Weinberg, A. C., et al. (2009). Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA, 302(14), 1557–1564.CrossRef
9.
go back to reference Zaghloul, M. S., Christodouleas, J. P., Smith, A., Abdallah, A., William, H., Khaled, H. M., et al. (2018). Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 trial. JAMA Surgery, 153(1), e174591–e174591.CrossRef Zaghloul, M. S., Christodouleas, J. P., Smith, A., Abdallah, A., William, H., Khaled, H. M., et al. (2018). Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy: a randomized phase 2 trial. JAMA Surgery, 153(1), e174591–e174591.CrossRef
10.
go back to reference Nygren, J., Ljungqvist, O., & Thorell, A. (2017). Enhanced recovery after surgery: ERAS. Surgical Patient Care (pp. 349–361). Cham: Springer.CrossRef Nygren, J., Ljungqvist, O., & Thorell, A. (2017). Enhanced recovery after surgery: ERAS. Surgical Patient Care (pp. 349–361). Cham: Springer.CrossRef
11.
go back to reference Kulkarni, G. S., Hermanns, T., Wei, Y., Bhindi, B., Satkunasivam, R., Athanasopoulos, P., et al. (2017). Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. Journal of Clinical Oncology, 35(20), 2299–2305.CrossRef Kulkarni, G. S., Hermanns, T., Wei, Y., Bhindi, B., Satkunasivam, R., Athanasopoulos, P., et al. (2017). Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. Journal of Clinical Oncology, 35(20), 2299–2305.CrossRef
12.
go back to reference Glatzer, M., Panje, C. M., Sirén, C., Cihoric, N., & Putora, P. M. (2018). Decision making criteria in oncology. Oncology, 98(6), 39–47. Glatzer, M., Panje, C. M., Sirén, C., Cihoric, N., & Putora, P. M. (2018). Decision making criteria in oncology. Oncology, 98(6), 39–47.
16.
go back to reference Mason, S. J., Catto, J. W., Downing, A., Bottomley, S. E., Glaser, A. W., & Wright, P. (2018). Evaluating patient-reported outcome measures (PROM s) for bladder cancer: a systematic review using the CO nsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU International, 122(5), 760–773.CrossRef Mason, S. J., Catto, J. W., Downing, A., Bottomley, S. E., Glaser, A. W., & Wright, P. (2018). Evaluating patient-reported outcome measures (PROM s) for bladder cancer: a systematic review using the CO nsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist. BJU International, 122(5), 760–773.CrossRef
17.
go back to reference Tamburini, M. (2001). Health-related quality of life measures in cancer. Annals of Oncology, 12(suppl_3), S7–S10.CrossRef Tamburini, M. (2001). Health-related quality of life measures in cancer. Annals of Oncology, 12(suppl_3), S7–S10.CrossRef
18.
go back to reference Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132–140.CrossRef Aromataris, E., Fernandez, R., Godfrey, C. M., Holly, C., Khalil, H., & Tungpunkom, P. (2015). Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. International Journal of Evidence-Based Healthcare, 13(3), 132–140.CrossRef
19.
go back to reference Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., et al. (2017). AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 358, j4008.CrossRef Shea, B. J., Reeves, B. C., Wells, G., Thuku, M., Hamel, C., Moran, J., et al. (2017). AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 358, j4008.CrossRef
27.
go back to reference Perlis, N., Krahn, M., Alibhai, S., Finelli, A., Ritvo, P., Bremner, K. E., et al. (2014). Conceptualizing global health-related quality of life in bladder cancer. Quality of Life Research: An International Journal of quality of Life Aspects of Treatment, Care and Rehabilitation, 23(8), 2153–2167. https://doi.org/10.1007/s11136-014-0685-9.CrossRef Perlis, N., Krahn, M., Alibhai, S., Finelli, A., Ritvo, P., Bremner, K. E., et al. (2014). Conceptualizing global health-related quality of life in bladder cancer. Quality of Life Research: An International Journal of quality of Life Aspects of Treatment, Care and Rehabilitation, 23(8), 2153–2167. https://​doi.​org/​10.​1007/​s11136-014-0685-9.CrossRef
29.
go back to reference Cerruto, M. A., D'Elia, C., Siracusano, S., Gedeshi, X., Mariotto, A., Iafrate, M., et al. (2016). Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. European Journal of Surgical Oncology, 42(3), 343–360. https://doi.org/10.1016/j.ejso.2015.10.001.CrossRef Cerruto, M. A., D'Elia, C., Siracusano, S., Gedeshi, X., Mariotto, A., Iafrate, M., et al. (2016). Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. European Journal of Surgical Oncology, 42(3), 343–360. https://​doi.​org/​10.​1016/​j.​ejso.​2015.​10.​001.CrossRef
31.
go back to reference Ghosh, A., & Somani, B. (2016). Recent trends in post-cystectomy health-related quality of life (QOL) favours neobladder diversion: Systematic review of the literature. Journal of Urology, 195(4), e751. Ghosh, A., & Somani, B. (2016). Recent trends in post-cystectomy health-related quality of life (QOL) favours neobladder diversion: Systematic review of the literature. Journal of Urology, 195(4), e751.
33.
go back to reference Cerruto, M. A., D'Elia, C., Siracusano, S., Porcaro, A. B., Cacciamani, G., De Marchi, D., et al. (2017). Is health-related quality of life after radical cystectomy using validated questionnaires really better in patients with ileal orthotopic neobladder compared to ileal conduit: A meta-analysis of retrospective comparative studies. Current Urology, 10(2), 57–68. https://doi.org/10.1159/000447153.CrossRef Cerruto, M. A., D'Elia, C., Siracusano, S., Porcaro, A. B., Cacciamani, G., De Marchi, D., et al. (2017). Is health-related quality of life after radical cystectomy using validated questionnaires really better in patients with ileal orthotopic neobladder compared to ileal conduit: A meta-analysis of retrospective comparative studies. Current Urology, 10(2), 57–68. https://​doi.​org/​10.​1159/​000447153.CrossRef
36.
go back to reference Veskimae, E., Neuzillet, Y., Rouanne, M., MacLennan, S., Lam, T. B. L., Yuan, Y. H., et al. (2017). Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU International, 120(1), 12–24. https://doi.org/10.1111/bju.13819.CrossRef Veskimae, E., Neuzillet, Y., Rouanne, M., MacLennan, S., Lam, T. B. L., Yuan, Y. H., et al. (2017). Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer. BJU International, 120(1), 12–24. https://​doi.​org/​10.​1111/​bju.​13819.CrossRef
38.
go back to reference Al-Tartir, T., Raza, S., Alotaibi, M., Khan, A., Hara, I., Fujisawa, M., et al. (2015). Robot-assisted surgical approach to bladder cancer: A decade of progress! Minerva Urologica E Nefrologica, 67(1), 55–63. Al-Tartir, T., Raza, S., Alotaibi, M., Khan, A., Hara, I., Fujisawa, M., et al. (2015). Robot-assisted surgical approach to bladder cancer: A decade of progress! Minerva Urologica E Nefrologica, 67(1), 55–63.
40.
go back to reference Tan, W. S., Khetrapal, P., Tan, W. P., Rodney, S., Chau, M., & Kelly, J. D. (2016). Robotic assisted radical cystectomy with extracorporeal urinary diversion does not show a benefit over open radical cystectomy: A systematic review and meta-analysis of randomised controlled trials. PLoS ONE. https://doi.org/10.1371/journal.pone.0166221.CrossRef Tan, W. S., Khetrapal, P., Tan, W. P., Rodney, S., Chau, M., & Kelly, J. D. (2016). Robotic assisted radical cystectomy with extracorporeal urinary diversion does not show a benefit over open radical cystectomy: A systematic review and meta-analysis of randomised controlled trials. PLoS ONE. https://​doi.​org/​10.​1371/​journal.​pone.​0166221.CrossRef
41.
42.
45.
go back to reference Kimura, S., Iwata, T., Foerster, B., Fossati, N., Briganti, A., Nasu, Y., et al. (2019). Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis. International Journal of Urology, 26(8), 760–774.CrossRef Kimura, S., Iwata, T., Foerster, B., Fossati, N., Briganti, A., Nasu, Y., et al. (2019). Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis. International Journal of Urology, 26(8), 760–774.CrossRef
46.
go back to reference Sathianathen, N. J., Kalapara, A., Frydenberg, M., Lawrentschuk, N., Weight, C. J., Parekh, D., et al. (2018). Robotic-assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis. The Journal of Urology, 201(4), 715–720.CrossRef Sathianathen, N. J., Kalapara, A., Frydenberg, M., Lawrentschuk, N., Weight, C. J., Parekh, D., et al. (2018). Robotic-assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis. The Journal of Urology, 201(4), 715–720.CrossRef
51.
go back to reference Shi, H., Yu, H., Bellmunt, J., Leow, J. J., Chen, X., Guo, C., et al. (2018). Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis. Quality of Life Research, 27(11), 2759–2775. https://doi.org/10.1007/s11136-018-1902-8.CrossRef Shi, H., Yu, H., Bellmunt, J., Leow, J. J., Chen, X., Guo, C., et al. (2018). Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis. Quality of Life Research, 27(11), 2759–2775. https://​doi.​org/​10.​1007/​s11136-018-1902-8.CrossRef
52.
go back to reference Ziouziou, I., Irani, J., Wei, J. T., Karmouni, T., El Khader, K., Koutani, A., et al. (2018). Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis. Progres en Urologie, 28(5), 241–250. https://doi.org/10.1016/j.purol.2018.02.001.CrossRef Ziouziou, I., Irani, J., Wei, J. T., Karmouni, T., El Khader, K., Koutani, A., et al. (2018). Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis. Progres en Urologie, 28(5), 241–250. https://​doi.​org/​10.​1016/​j.​purol.​2018.​02.​001.CrossRef
55.
go back to reference Desai, M. M., & Gill, I. S. J. E. U. (2015). The devil is in the details": Randomized trial of robotic versus open radical cystectomy. European Urology, 67(6), 1053–1055.CrossRef Desai, M. M., & Gill, I. S. J. E. U. (2015). The devil is in the details": Randomized trial of robotic versus open radical cystectomy. European Urology, 67(6), 1053–1055.CrossRef
56.
go back to reference Catto, J. W., Khetrapal, P., Ambler, G., Sarpong, R., Khan, M. S., Tan, M., et al. (2018). Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): Protocol for a randomised controlled trial with internal feasibility study. British Medical Journal Open, 8(8), e020500. Catto, J. W., Khetrapal, P., Ambler, G., Sarpong, R., Khan, M. S., Tan, M., et al. (2018). Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): Protocol for a randomised controlled trial with internal feasibility study. British Medical Journal Open, 8(8), e020500.
58.
go back to reference Zhang, S., Yu, Y. H., Zhang, Y., Qu, W., & Li, J. (2015). Radiotherapy in muscle-invasive bladder cancer: The latest research progress and clinical application. American Journal of Cancer Research, 5(2), 854–868. Zhang, S., Yu, Y. H., Zhang, Y., Qu, W., & Li, J. (2015). Radiotherapy in muscle-invasive bladder cancer: The latest research progress and clinical application. American Journal of Cancer Research, 5(2), 854–868.
60.
go back to reference Van Hemelrijck, M., Sparano, F., Josephs, D., Sprangers, M., Cottone, F., & Efficace, F. (2019). Patient-reported outcomes in randomised clinical trials of bladder cancer: An updated systematic review. BMC Urology, 19(1), 86.CrossRef Van Hemelrijck, M., Sparano, F., Josephs, D., Sprangers, M., Cottone, F., & Efficace, F. (2019). Patient-reported outcomes in randomised clinical trials of bladder cancer: An updated systematic review. BMC Urology, 19(1), 86.CrossRef
61.
go back to reference Boormans, J. L., & Zwarthoff, E. C. J. B. C. (2016). Limited funds for bladder cancer research and what can we do about it. Bladder Cancer, 2(1), 49–51.CrossRef Boormans, J. L., & Zwarthoff, E. C. J. B. C. (2016). Limited funds for bladder cancer research and what can we do about it. Bladder Cancer, 2(1), 49–51.CrossRef
62.
go back to reference Aluwini, S., Liem, E., Boormans, J., Antonisse, I., Praag, J. O., Kirkels, W., et al. (2015). Long-term treatment outcome of local recurrences after bladder preservation with brachytherapy for bladder carcinoma. International Journal of Radiation Oncology Biology Physics, 93(3), E216–E217.CrossRef Aluwini, S., Liem, E., Boormans, J., Antonisse, I., Praag, J. O., Kirkels, W., et al. (2015). Long-term treatment outcome of local recurrences after bladder preservation with brachytherapy for bladder carcinoma. International Journal of Radiation Oncology Biology Physics, 93(3), E216–E217.CrossRef
Metagegevens
Titel
Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review
Auteurs
Elke Rammant
Lisa Van Wilder
Mieke Van Hemelrijck
Nele S. Pauwels
Karel Decaestecker
Charles Van Praet
Renée Bultijnck
Piet Ost
Thomas Van Vaerenbergh
Sofie Verhaeghe
Ann Van Hecke
Valérie Fonteyne
Publicatiedatum
06-06-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 11/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02544-z

Andere artikelen Uitgave 11/2020

Quality of Life Research 11/2020 Naar de uitgave